Trial Profile
Chronobiology and Chronopharmacology to Prevent Sickle Cell Kidney Disease
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 18 May 2022
Price :
$35
*
At a glance
- Drugs Losartan (Primary)
- Indications Kidney disorders
- Focus Therapeutic Use
- 05 May 2022 Status changed from completed to discontinued.
- 08 Jul 2021 Status changed from active, no longer recruiting to completed.
- 02 Jul 2020 Planned End Date changed from 1 Apr 2020 to 1 Apr 2021.